The Long-Term Effect of Early Anti-Tumor Necrosis Factor on Restoration of Growth in Pediatric Crohn's Disease
Overview
Overview
Authors
Authors
Affiliations
Affiliations
Soon will be listed here.
Citing Articles
Mitchel E, Huang J, Zemel B, Baldassano R, Albenberg L, Denburg M J Pediatr Gastroenterol Nutr. 2024; 78(1):85-94.
PMID: 38291691 PMC: 11823676. DOI: 10.1002/jpn3.12063.
Choi Y, Kim T, Park D, Chung J, Kim K, Kwon K Int J Colorectal Dis. 2019; 34(10):1713-1721.
PMID: 31471699 DOI: 10.1007/s00384-019-03368-1.
References
1.
Griffin L, Thayu M, Baldassano R, DeBoer M, Zemel B, Denburg M
. Improvements in Bone Density and Structure during Anti-TNF-α Therapy in Pediatric Crohn's Disease. J Clin Endocrinol Metab. 2015; 100(7):2630-9.
PMC: 4490303.
DOI: 10.1210/jc.2014-4152.
View
2.
Hyams J, Walters T, Crandall W, Kugathasan S, Griffiths A, Blank M
. Safety and efficacy of maintenance infliximab therapy for moderate-to-severe Crohn's disease in children: REACH open-label extension. Curr Med Res Opin. 2011; 27(3):651-62.
DOI: 10.1185/03007995.2010.547575.
View
3.
Lee E, Moon J, Ko J, Yang H, Jang J, Kim J
. Effect of the Baseline Vitamin D Level on Growth Outcome in Pediatric Crohn Disease. Pediatr Gastroenterol Hepatol Nutr. 2017; 20(1):41-46.
PMC: 5385306.
DOI: 10.5223/pghn.2017.20.1.41.
View
4.
Hyams J, Crandall W, Kugathasan S, Griffiths A, Olson A, Johanns J
. Induction and maintenance infliximab therapy for the treatment of moderate-to-severe Crohn's disease in children. Gastroenterology. 2007; 132(3):863-73.
DOI: 10.1053/j.gastro.2006.12.003.
View
5.
Cameron F, Altowati M, Rogers P, McGrogan P, Anderson N, Bisset W
. Disease Status and Pubertal Stage Predict Improved Growth in Antitumor Necrosis Factor Therapy for Pediatric Inflammatory Bowel Disease. J Pediatr Gastroenterol Nutr. 2016; 64(1):47-55.
DOI: 10.1097/MPG.0000000000001379.
View